Voices
Felipe Couñago: Role of Radiation Oncologists in Prescribing PARP Inhibitors in Advanced Prostate Cancer
Felipe Couñago/genesiscare.com

Felipe Couñago: Role of Radiation Oncologists in Prescribing PARP Inhibitors in Advanced Prostate Cancer

Felipe Couñago, Medical Director at GenesisCare Spain, shared a post on X:

“New publication from SEOR-URONCOR in Actas Urológicas Españolas

Our position paper supports the role of radiation oncologists in prescribing PARP inhibitors in advanced PCa

  • Multidisciplinary care
  • Precision oncology
  • Patient-centered decisions”

Title: Position paper of the Spanish Society of Radiotherapeutic Oncology (SEOR) and its genitourinary tumors group (URONCOR) on the prescription of PARP inhibitors in advanced prostate cancer

Authors: P. Diezhandino, F. Couñago, A. Ocanto, A. Gómez de Iturriaga, A. Conde, X. Maldonado, J. Serrano, F. López-Campos

Read the Full Article on Actas Urológicas Españolas

Felipe Couñago: Role of Radiation Oncologists in Prescribing PARP Inhibitors in Advanced Prostate Cancer

More posts featuring Felipe Couñago.

A. Conde A. Gomez de Iturriaga A. Ocanto cancer F. Couñago F. López-Campos Felipe Couñago J. Serrano OncoDaily Oncology P. Diezhandino X. Maldonado